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Localization of Double-Strand Break
Repair Proteins to Viral Replication
Compartments following Lytic
Reactivation of Kaposi’s Sarcoma-
Associated Herpesvirus
Robert Hollingworth, Richard D. Horniblow, Calum Forrest,* Grant S. Stewart,
Roger J. Grand
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom
ABSTRACT Double-strand breaks (DSBs) in DNA are recognized by the Ku70/80 het-
erodimer and the MRE11-RAD50-NBS1 (MRN) complex and result in activation of the
DNA-PK and ATM kinases, which play key roles in regulating the cellular DNA dam-
age response (DDR). DNA tumor viruses such as Kaposi’s sarcoma-associated herpes-
virus (KSHV) are known to interact extensively with the DDR during the course of
their replicative cycles. Here we show that during lytic ampliﬁcation of KSHV DNA,
the Ku70/80 heterodimer and the MRN complex consistently colocalize with viral ge-
nomes in replication compartments (RCs), whereas other DSB repair proteins form
foci outside RCs. Depletion of MRE11 and abrogation of its exonuclease activity neg-
atively impact viral replication, while in contrast, knockdown of Ku80 and inhibition
of the DNA-PK enzyme, which are involved in nonhomologous end joining (NHEJ)
repair, enhance ampliﬁcation of viral DNA. Although the recruitment of DSB-sensing
proteins to KSHV RCs is a consistent occurrence across multiple cell types, activation
of the ATM-CHK2 pathway during viral replication is a cell line-speciﬁc event, indi-
cating that recognition of viral DNA by the DDR does not necessarily result in activa-
tion of downstream signaling pathways. We have also observed that newly repli-
cated viral DNA is not associated with cellular histones. Since the presence and
modiﬁcation of these DNA-packaging proteins provide a scaffold for docking of mul-
tiple DNA repair factors, the absence of histone deposition may allow the virus to
evade localization of DSB repair proteins that would otherwise have a detrimental
effect on viral replication.
IMPORTANCE Tumor viruses are known to interact with machinery responsible for
detection and repair of double-strand breaks (DSBs) in DNA, although detail con-
cerning how Kaposi’s sarcoma-associated herpesvirus (KSHV) modulates these cellu-
lar pathways during its lytic replication phase was previously lacking. By undertaking
a comprehensive assessment of the localization of DSB repair proteins during KSHV
replication, we have determined that a DNA damage response (DDR) is directed to
viral genomes but is distinct from the response to cellular DNA damage. We also
demonstrate that although recruitment of the MRE11-RAD50-NBS1 (MRN) DSB-
sensing complex to viral genomes and activation of the ATM kinase can promote
KSHV replication, proteins involved in nonhomologous end joining (NHEJ) repair re-
strict ampliﬁcation of viral DNA. Overall, this study extends our understanding of the
virus-host interactions that occur during lytic replication of KSHV and provides a
deeper insight into how the DDR is manipulated during viral infection.
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Kaposi’s sarcoma-associated herpesvirus (KSHV) is a human tumor virus that isresponsible for the vascular malignancy known as Kaposi’s sarcoma (KS) as well as
the B cell lymphoproliferative disorders primary effusion lymphoma (PEL) and multi-
centric Castleman’s disease (MCD) (1–3). KSHV typically establishes an asymptomatic
lifelong latent infection characterized by a restricted viral gene expression program that
facilitates evasion of host immune surveillance. However, in order to amplify its genetic
material and produce infectious virions, KSHV utilizes an alternate life cycle phase
known as lytic replication. Lytic replication of herpesviruses involves regulated and
sequential expression of viral genes that are divided into classes known as immediate
early, early, and late (4). KSHV immediate early viral genes include ORF50/RTA, which is
required for initiation of the full lytic cascade and transactivates other viral genes
required for complete lytic replication (5, 6). Early lytic gene products include six viral
replication factors required for synthesis of viral DNA as well as other proteins that
modulate host cell signaling pathways (7). Late viral genes, expression of which occurs
following the onset of viral genome ampliﬁcation, typically encode structural proteins
that make up the mature viral capsid (8). Lytic replication of herpesviruses involves the
formation of large globular domains in the host cell nucleus known as viral replication
compartments (RCs), which contain newly synthesized viral DNA. The precise nature
and function of these viral RCs remain under investigation, although it has been
suggested that they serve to concentrate viral and cellular proteins required for viral
replication while at the same time shielding viral genomes from detection by the
cellular immune machinery (9). Both theta-type and rolling-circle replication mecha-
nisms are believed to play a role in lytic replication of herpesvirus DNA, the end
products of which are long concatemers containing unit-length viral genomes (10).
Recombination is also known to occur frequently between viral genomes, while a
recombination-dependent mechanism could also contribute to the generation of
concatemeric viral DNA (11).
The DNA damage response (DDR) encompasses multiple signaling pathways re-
sponsible for the detection and reversal of DNA lesions that can result from the actions
of endogenous cellular processes and exogenous agents. Proteins that participate in
this response are often categorized as either sensor, transducer, or effector molecules,
depending on their role within DDR signaling cascades. DNA lesions can take many
forms, although double-strand breaks (DSBs), in which both strands of the double helix
are severed, are particularly cytotoxic due to their tendency to cause translocations,
fusions, and deletions when incorrectly repaired (12). ATM and DNA-PK are two
members of the phosphatidylinositol 3-kinase-related kinase family of enzymes that
regulate the response to cellular DSBs (13). The MRE11-RAD50-NBS1 (MRN) complex,
which is involved in DNA replication, DNA repair, and checkpoint activation, is often
described as a “ﬁrst responder” to DNA damage, as it recognizes and binds DSBs and
plays a role in ATM recruitment and activation (14). ATM is rapidly activated following
the formation of DSBs and orchestrates the cellular response to this DNA lesion by
phosphorylating multiple substrates that regulate cell cycle checkpoints, DNA repair,
and apoptosis (15). Both ATM and DNA-PK can phosphorylate the histone variant H2AX
on serine 139 (H2AX) on either side of the break site, which allows binding of MDC1
to H2AX via its BRCT repeat domain (16–18). Subsequent phosphorylation of MDC1 by
ATM allows recruitment of the E3 ubiquitin ligase RNF168, which ubiquitylates histone
H2A on K15 to allow binding of 53BP1 (19–21). 53BP1 plays a role in DNA repair and
checkpoint activation and is used as a speciﬁc marker of DSBs in immunoﬂuorescence
(IF) microscopy (22). Another key substrate of ATM is CHK2, activation of which can
promote cell cycle arrest and apoptosis through phosphorylation of multiple proteins,
including p53 and CDC25A (23, 24).
DNA-PK is a central component of the nonhomologous end joining (NHEJ) repair
pathway, which operates throughout the cell cycle and involves direct religation of
severed DNA molecules. During NHEJ, the Ku70/80 heterodimer recognizes and binds
DSBs before recruiting the DNA-PK catalytic subunit (DNA-PKcs) to form the active
DNA-PK holoenzyme. Numerous factors are involved in DNA end processing before the
Hollingworth et al. Journal of Virology
November 2017 Volume 91 Issue 22 e00930-17 jvi.asm.org 2
 o
n
 D
ecem
ber 7, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
DNA ligase IV/XRCC4 complex ligates the break, facilitated by accessory proteins such
as XLF and PAXX (25, 26). The other principal pathway that corrects DSBs is known as
homologous recombination (HR) and is active only in the S and G2 phases when a sister
chromatid is available to provide a template for accurate repair. HR is preceded by
localized DNA resection that is initiated by the MRN complex and is enhanced by
recruitment of BRCA1 and CtIP (27, 28). The trimeric RPA complex protects the resulting
single-stranded DNA (ssDNA) before BRCA2 or RAD52 mediates its replacement by
RAD51 to form a nucleoﬁlament that invades the undamaged homologous DNA strand
(29). Following homology searching and annealing of the nucleoﬁlament to a homol-
ogous undamaged region, DNA polymerases extend the damaged strand, while nu-
cleases then resolve the resulting DNA structures to complete the repair process (30).
It is now clear that herpesviruses interact extensively with pathways responsible for
detection and repair of cellular DSBs, and these interactions occur at multiple stages of
their reproductive cycles. DSB repair proteins such as DNA-PKcs and BRCA1, for
example, can interact with herpesvirus genomes following de novo infection and
trigger innate immune responses against the virus (31, 32). Activation of the ATM-CHK2
arm of the DDR has also been observed during replication of several species of
herpesvirus, including KSHV, Epstein-Barr virus (EBV), herpes simplex virus 1 (HSV-1),
human cytomegalovirus (HMCV), and murine gammaherpesvirus 68 (MHV-68), al-
though there has been disagreement regarding the contribution of this event to
successful viral replication (33–37). While DSB repair proteins participate in the cellular
antiviral response, they have also been observed at sites of herpesvirus DNA synthesis
in the nucleus, where they have been implicated in efﬁcient replication of viral
genomes (38, 39). Factors that participate in HR repair, such as RPA32, MRE11, RAD51,
and RAD52, for example, have been shown to directly associate with replicating EBV
DNA, while knockdown of RPA32 and RAD51 dramatically attenuates EBV lytic replica-
tion (38).
In the case of KSHV, activation of a DSB-speciﬁc DDR has been demonstrated
following initial viral entry and during the lytic replication program, and in both cases
some aspects of DDR activation appear to play a positive role in the viral life cycle (33,
40). The KSHV lytic protein ORF57/MTA has also been shown to cause DSBs when
expressed alone through the formation of R loops in cellular DNA (41). We have
previously reported that KSHV lytic replication in B cells leads to activation of a
DSB-speciﬁc DDR that includes activation of the ATM and DNA-PK kinases and phos-
phorylation of their downstream substrates (33). Inhibition of viral DNA ampliﬁcation
and late lytic gene expression did not reduce phosphorylation of DDR proteins,
indicating that immediate early and early lytic gene expression are sufﬁcient to cause
DDR activation.
In the current study, we have undertaken a comprehensive assessment of the
localization of DSB repair proteins in cells containing lytic KSHV and have also evaluated
the contribution of key regulators of the DSB response to viral replication efﬁciency.
Using IF microscopy, we revealed that during the KSHV lytic replication program,
protein complexes involved in the initial recognition of DSBs consistently colocalize
with viral genomes within RCs while DSB repair foci also form outside viral replication
domains. We also demonstrate that cellular histones are not associated with newly
ampliﬁed viral DNA and that recognition of viral genomes by the DSB-sensing appa-
ratus does not necessarily activate wider DDR signaling cascades. Overall, these results
highlight signiﬁcant interplay between KSHV and the cellular DSB repair machinery
following viral reactivation and reveal both positive and negative consequences of
these interactions for the viral life cycle.
RESULTS
DSB-sensing proteins are recruited to KSHV RCs. As outlined above, DSB repair
pathways are initiated following recognition of DNA lesions by sensor proteins. To
determine if proteins involved in initial detection of DSBs localize to KSHV genomes
during the lytic cycle, IF microscopy was carried out on EA.hy926-RTA cells containing
DSB Repair Factor Localization during KSHV Replication Journal of Virology
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lytic KSHV. KSHV RCs were identiﬁed using antibodies against the viral ssDNA binding
protein (SSB) or the viral processivity factor (PF8), which are both involved in the
replication of KSHV DNA. For each DSB repair protein assessed, a minimum of 100 cells
containing viral RCs were examined for each of three independent experiments.
Using antibodies against MRE11, NBS1, and RAD50, we observed that the complete
MRN complex, which recognizes and binds DSBs, is present at KSHV RCs following viral
reactivation (Fig. 1). The MRN complex was observed tightly associated with RCs in all
of the cells examined and was found to localize to these replication domains as soon
as they were detectable, and it also remained associated as RCs expanded to ﬁll the
nucleus (data not shown).
Another protein complex that associates with DSBs is the Ku70/80 heterodimer,
which precedes recruitment of DNA-PKcs to form the DNA-PK holoenzyme that is
required for NHEJ repair (42). As with the MRN complex, both Ku70 and Ku80 were
observed localized to KSHV RCs in all of the cells examined (Fig. 1). For all the DNA
repair proteins assessed using IF microscopy, staining was carried out using a preex-
traction step which removes the majority of unbound nucleoplasmic protein but
preserves the chromatin-associated fraction (43). The presence of both the MRN
complex and Ku70/80 at KSHV RCs following preextraction suggests that these proteins
were associating with replicating viral genomes. Overall, these images indicate that
ampliﬁcation of the KSHV genome involves the formation of DSBs in viral DNA that are
recognized by the cellular DDR.
Downstream HR proteins are not consistently observed at KSHV RCs. Following
localization to DSBs, the MRN complex is important for the early stages of HR repair by
initiating DNA resection (44). The efﬁciency of DNA resection has been found to be
enhanced by the formation of a complex involving MRN, BRCA1, and CtIP (27). We
therefore examined the localization of BRCA1 and CtIP during KSHV lytic replication to
determine whether these factors were also associated with viral RCs (Fig. 2A). As before,
the localization of these proteins was examined in a minimum of 100 cells containing
KSHV RCs in each of three independent experiments. In contrast to members of the
FIG 1 Localization of DSB-sensing complexes during lytic replication of KSHV. EA.hy926-RTA cells
containing latent KSHV were treated with doxycycline (Dox) for 48 h or left untreated prior to IF analysis
of nuclear localization of MRE11, NBS1, RAD50, Ku70, and Ku80 in relation to KSHV RCs marked by the
viral SSB protein. Scale bars represent 5 m.
Hollingworth et al. Journal of Virology
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MRN complex, BRCA1 was not seen at KSHV RCs in the majority of the cells examined.
However, in 22% of the cells assessed, at least some BRCA1 protein could be observed
associated with KSHV genomes, while in those cells where BRCA1 did not localize to
viral genomes, the protein often formed visible foci in the vicinity of viral RCs (Fig. 2A).
Due to the lack of a commercial CtIP antibody that is compatible with IF microscopy,
the localization of this protein was assessed by infection of a previously developed
U2OS cell line that expresses doxycycline-inducible green ﬂuorescent protein (GFP)-
tagged CtIP (45) (Fig. 2A). Similar to BRCA1, CtIP was typically not observed tightly
associated with viral genomes and was often not detectable in cells containing lytic
virus. However, in 15% of the cells examined, GFP-CtIP was observed localized to viral
RCs. These results suggest that despite the consistent localization of the MRN complex
to viral genomes, DSB repair factors that associate with MRN are only occasionally
recruited to KSHV replication domains.
FIG 2 Localization of HR repair factors during lytic replication of KSHV. (A) EA.hy926-RTA cells containing latent
KSHV were treated with doxycycline for 48 h or left untreated prior to IF analysis of nuclear localization of BRCA1
in relation to KSHV RCs marked by the viral SSB protein. Latently infected U2OS cells expressing GFP-CtIP were
treated with sodium butyrate for 48 h or left untreated prior to IF analysis of GFP-CtIP localization in relation to
KSHV RCs marked by the viral SSB protein. (B) EA.hy926-RTA cells were prepared as described above prior to IF
analysis of nuclear localization of the HR repair factors RAD51, RAD52, and RAD54B in relation to KSHV RCs marked
by the viral PF8 protein. Scale bars represent 5 m.
DSB Repair Factor Localization during KSHV Replication Journal of Virology
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Additional factors involved in HR repair downstream of the DNA resection stage
have previously been implicated in replication of herpesvirus DNA (38, 46). We there-
fore examined the localization of several other proteins known to participate in HR:
RAD51, which forms nucleoprotein ﬁlaments that invade homologous DNA templates;
RAD52, which promotes RAD51 loading and cDNA annealing; and RAD54B, which is
involved in localized chromatin remodelling (47–49) (Fig. 2B). In contrast to the
consistent localization of the MRN complex and Ku70/80, RAD51 and RAD54B were
never observed localized to KSHV RCs in any of the cells examined. However, in 82% of
the cells assessed, RAD52 was observed concentrated in and around sites of viral
replication, although it did not appear to be as tightly associated with these replication
domains as MRN and Ku70/80. It appears, therefore, that while DSB-sensing complexes
are always observed at viral RCs, downstream HR repair proteins are not consistently
recruited to these viral replication sites.
DSB repair foci form outside KSHV RCs. Since the presence of Ku70/80 and the
MRN complex at sites of KSHV replication suggests the formation of DSBs in viral DNA,
the localization of other proteins that form foci in response to DSBs was also examined
in relation to KSHV RCs (Fig. 3). Phosphorylation of H2AX at either side of DSBs
facilitates an interaction between H2AX and MDC1 that subsequently leads to recruit-
ment of 53BP1 (17, 19). IF staining was therefore carried out using antibodies against
H2AX, MDC1, and 53BP1 in control EA.hy926-RTA cells and in EA.hy926-RTA cells
treated with 4 Gy ionizing radiation (IR) to demonstrate the typical distribution of these
proteins in both unperturbed cells and cells containing high levels of DNA damage (Fig.
3A). In the absence of lytic replication or IR exposure, H2AX and MDC1 both displayed
a faint and diffuse nuclear staining pattern, while 53BP1 was either diffuse or concen-
trated in several foci that typically numbered less than ﬁve per cell. In contrast,
following exposure to IR, all three proteins formed numerous discrete foci across the
nucleus, indicating the occurrence of cellular DSBs. Staining for these proteins was then
carried out in EA.hy926-RTA cells containing lytic KSHV (Fig. 3A). All three DSB repair
factors formed foci in cells containing viral RCs, indicating that lytic replication leads to
formation of DSBs. However, unlike Ku70/80 and members of the MRN complex, these
factors were typically observed outside viral RCs and were often concentrated at the
margins of viral replication domains. Since 53BP1 foci are often used as a speciﬁc
marker of DSBs, the number of 53BP1 foci in cells containing KSHV RCs was then
quantiﬁed in at least 50 cells in three independent experiments and compared with the
number of foci in uninfected cells (Fig. 3A). This analysis revealed a signiﬁcant increase
in the number of 53BP1 foci in cells containing lytic virus, indicating an increase in the
formation of DSBs during this stage of the viral life cycle.
To conﬁrm the localization of MRE11, Ku80, H2AX, MDC1, and 53BP1 in relation to
KSHV RCs, confocal microscopy was used to generate composite micrographs with
orthogonal views from stacked images of EA.hy926-RTA cells containing viral replica-
tion domains (Fig. 3B). These images conﬁrm that MRE11 and Ku80 colocalize with viral
genomes within RCs, while H2AX, MDC1, and 53BP1 form foci that are typically
concentrated on the periphery of viral RCs. These images conﬁrm that while DSB
sensors localize to viral genomes, DSB repair foci also form outside viral RCs, suggesting
that DNA lesions occur in cellular chromatin during the lytic replication program.
Cellular histones do not associate with ampliﬁed viral DNA. While Ku70/80 and
the MRN complex have an afﬁnity for double-stranded DNA ends, recruitment of the
DSB repair factors MDC1 and 53PB1 and the formation of H2AX foci at DSB sites
require the presence and modiﬁcation of cellular histones (18, 19, 50). While latent
KSHV genomes are known to associate with histones, it is not clear whether KSHV DNA
synthesized during the lytic phase also associates with these cellular proteins. To
determine if histones associate with newly ampliﬁed KSHV DNA, we ﬁrst examined the
distribution of histones H1 and H3 in relation to KSHV RCs marked by PF8 (Fig. 4A). This
initial IF analysis indicated that these cellular histones are not concentrated within
KSHV RCs and are therefore not likely to be associated with replicating viral DNA.
Hollingworth et al. Journal of Virology
November 2017 Volume 91 Issue 22 e00930-17 jvi.asm.org 6
 o
n
 D
ecem
ber 7, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
We then used chromatin immunoprecipitation (ChIP) to determine if histone H3 is
enriched on viral DNA during ampliﬁcation of KSHV genomes in B cells. TREx BCBL-1-
RTA cells were treated with doxycycline for 0, 24, and 48 h, and chromatin preparations
were prepared by sonication. When these input chromatin preparations were cleaned
up and subjected to quantitative PCR (qPCR) analysis, there was an expected increase
in the amounts of viral DNA at 24 and 48 h following doxycycline treatment relative to
that for the 0-h controls (Fig. 4B). These chromatin samples were then subjected to
FIG 3 Formation of DSB repair foci during lytic replication of KSHV. (A) EA.hy926-RTA cells were exposed
to 4 Gy IR for 1 h or left untreated prior to IF analysis of H2AX, MCD1, and 53BP1 focus formation.
EA.hy926-RTA cells containing latent KSHV were then treated with doxycycline for 48 h to induce lytic
replication prior to IF analysis of the same DDR proteins in relation to KSHV RCs marked by the viral SSB
or PF8 protein. The numbers of 53BP1 foci in cells containing KSHV RCs (RCs) and in cells that do not
contain lytic virus (C) were counted in at least 50 cells per condition in three independent experiments.
All data bars represent the mean from three independent experiments, while error bars signify the
standard error of the mean (SEM). ***, P  0.001 (statistical analyses were performed using a two-tailed
and unpaired Student t test). (B) Confocal scanning microscopy was used to generate composite
micrographs from z-stack images of EA.hy926-RTA cells containing lytic KSHV. The images demonstrate
localization of MRE11, Ku80, H2AX, MDC1, and 53BP1 in relation to KSHV RCs marked by the viral SSB
or PF8 proteins. The side panels provide orthogonal views (xz and yz), while crosshairs show the cut point
through the x, y, and z axes of the image. Scale bars represent 5 m.
DSB Repair Factor Localization during KSHV Replication Journal of Virology
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immunoprecipitation using a ChIP-grade H3 antibody and an appropriate IgG control.
The relative amounts of viral DNA compared with cellular DNA in the immunoprecipi-
tated material were assessed by qPCR using primers speciﬁc for the viral ORF47 gene
and the cellular 2-microglobulin (B2m) gene, respectively (Fig. 4C). Background values
derived from IgG controls were subtracted from values derived from H3 ChIP samples,
and the data were subsequently normalized to cellular DNA by dividing the values for
viral DNA by the values for cellular DNA. Since the doxycycline-treated samples contain
newly ampliﬁed viral DNA, if this replicated DNA is associated with histone H3 then the
relative amount of viral DNA immunoprecipitated with a H3 antibody in relation to
cellular DNA should increase under these conditions, similar to the case for Fig. 4B. In
fact, following immunoprecipitation, the relative amount of viral DNA detected de-
creased moderately at 24 and 48 h after viral reactivation, indicating that newly
synthesized viral genomes in TREx BCBL-1-RTA cells are not associated with histone H3.
Because the viral primers used in this analysis are speciﬁc to only one part of the viral
genome, we also repeated the qPCR analysis using primers speciﬁc to the left viral
origin of lytic replication (OriLytL), which is approximately 45 kb away from ORF47 in
the viral genome (Fig. 4C). qPCR analysis of immunoprecipitated viral DNA using these
primers yielded a similar trend, with a decrease in the relative amounts of viral DNA at
24 and 48 h following doxycycline treatment. Overall, these results indicate that KSHV
evades deposition of cellular histones during lytic ampliﬁcation of viral DNA.
Functional ATM kinase and ATM-CHK2 activation is not essential for lytic
replication of KSHV. Recognition of a DSB by MRN typically results in activation of the
ATM kinase, which subsequently phosphorylates CHK2. We have previously reported
that lytic replication of KSHV in TREx BCBL-1-RTA cells leads to activation of the
ATM-CHK2 pathway and that attenuation of ATM signaling, using the speciﬁc ATM
kinase inhibitor KU-55933, has a negative effect on release of infectious virus in these
FIG 4 Association of cellular histones with ampliﬁed viral genomes. (A) EA.hy926-RTA cells containing
latent KSHV were treated with doxycycline for 48 h or left untreated prior to IF analysis of the distribution
of histones H1 and H3 in relation to KSHV RCs marked by the viral PF8 protein. Scale bars represent 5
m. (B and C) TREx BCBL-1-RTA cells were treated with doxycycline for 0, 24, and 48 h and chromatin
preparations were prepared by sonication. (B) Following DNA cleanup, the viral genome load was
determined using qPCR relative to the 0-h control. (C) Chromatin preparations were subjected to ChIP
for histone H3 or control IgG. Viral DNA was detected in immunoprecipitated material by qPCR using
primers speciﬁc to the ORF47 or OriLytL region of the KSHV genome. Following subtraction of back-
ground readings, values were normalized to cellular DNA detected using primers speciﬁc to 2-
microglobulin (Bm2). All data bars represent the mean from three independent experiments, while error
bars signify the SEM.
Hollingworth et al. Journal of Virology
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cells (33). Because the highest concentration of KU-55933 used previously was inefﬁ-
cient at inhibiting CHK2 phosphorylation and had a negative effect on cell viability, the
restrictive effect of inhibiting ATM on KSHV replication in B cells was conﬁrmed here
using KU-60019, an improved analogue of KU-55933 that has been reported to be 10
times more effective at inhibiting phosphorylation of ATM targets than its predecessor
(51). Application of 5 M KU-60019 to TREx BCBL-1-RTA cells prior to induction of lytic
replication inhibited phosphorylation of the ATM substrate CHK2 and led to a signiﬁ-
cant reduction in viral genome load compared to that with a dimethyl sulfoxide (DMSO)
control (Fig. 5A).
To further assess the importance of the ATM kinase for KSHV lytic replication,
ataxia-telangiectasia (AT) ﬁbroblasts, which have a mutated form of the ATM gene, and
control ﬁbroblasts with functional ATM were grown on glass coverslips and infected
with KSHV derived from TREx BCBL-1-RTA cells. The cells were subsequently treated
with sodium butyrate, a histone deacetylase inhibitor known to promote lytic replica-
tion in latently infected cells (52). After 72 h, both cell lines were examined for
expression of KSHV lytic proteins using IF microscopy (Fig. 5B). In both control and AT
ﬁbroblasts, cells containing KSHV RCs marked by viral SSB and expressing the late viral
K8.1 protein were observed, indicating that both lines can support ampliﬁcation of viral
DNA and late lytic gene expression. To compare the numbers of cells from each
ﬁbroblast line containing lytic KSHV, the numbers of control and AT ﬁbroblasts con-
taining viral RCs were counted across a coverslip for each repeat experiment (Fig. 5C).
To assess infectious virus release, the supernatants from these cells were applied to
uninfected EA.hy926 cells, and the number of these cells infected with KSHV across a
coverslip was determined after 48 h by using IF analysis of LANA expression (Fig. 5C).
Although both cell lines clearly support KSHV lytic replication and production of
infectious progeny, replication levels were signiﬁcantly lower in AT cells than in the
control line, suggesting that lack of functional ATM does have a negative effect on
KSHV replication efﬁciency. These ﬁndings indicate that despite lacking functional ATM
kinase, AT ﬁbroblasts can support ampliﬁcation of viral DNA during the lytic cycle,
although at reduced levels compared to a control line with functional ATM.
We were also interested to determine if activation of the ATM-CHK2 pathway
observed in B cells was a consistent event across other cell types. We therefore
examined activation of the DDR during lytic replication in VK219-RTA cells, which are
modiﬁed Vero cells containing a recombinant GFP/red ﬂuorescent protein (RFP)-
expressing KSHV and a doxycycline-inducible ORF50/RTA gene (53) (Fig. 5D). Although
not a representative model for in vivo KSHV infection, this cell line is useful here
because, unlike for many other latently infected cell lines, treatment of VK219-RTA cells
with a combination of doxycycline and sodium butyrate results in highly efﬁcient
induction of the lytic replication program, which facilitates measurement of viral
replication levels and detection of phosphorylated DDR proteins. Lytic replication was
therefore induced in VK219-RTA cells, and phosphorylation of H2AX, CHK2, and ATM
was assessed in comparison to that in uninfected Vero cells treated with the same
concentrations of doxycycline and sodium butyrate. Detection of the lytic proteins SSB
and K8.1A was used to conﬁrm viral reactivation, while VK219-RTA cells exposed to
either 20 J m2 UV radiation for 6 h or 6 Gy IR for 1 h were used as positive controls
for DDR activation. Induction of lytic replication in this cell line led to robust phos-
phorylation of H2AX, indicating DNA damage, although surprisingly, no obvious in-
crease in phosphorylation of ATM or its substrate CHK2 could be observed. This
indicates that activation of the ATM-CHK2 pathway during KSHV lytic replication is a cell
line-speciﬁc event.
Since ATM activation is facilitated by recruitment of the MRN complex to DSBs, this
led us to ask whether the localization of DSB-sensing proteins to viral RCs was also a cell
line-speciﬁc occurrence. The localization of MRE11 and Ku80 during lytic replication was
therefore examined in both TREx BCBL-1-RTA cells and Vero cells (Fig. 5E). Vero cells de
novo infected with TREx BCBL-1-RTA-derived KSHV were used here, since the GFP/RFP-
expressing recombinant virus contained within VK219-RTA cells is not compatible with
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three-color IF microscopy. As with EA.hy926-RTA cells, MRE11 and Ku80 were consis-
tently localized to viral RCs in these cell lines, indicating that recruitment of DSB-
sensing proteins to viral genomes is a consistent event during KSHV replication across
multiple cell types. In summary, these ﬁndings suggest that although the ATM kinase
may enhance KSHV replication in B cells and ﬁbroblasts, ATM is not absolutely required
for lytic replication of KSHV. In addition, since the MRN complex is associated with viral
RCs in Vero cells, but the ATM-CHK2 pathway is not activated during KSHV replication
FIG 5 Contribution of the ATM kinase to efﬁcient KSHV replication. (A) TREx BCBL-1-RTA cells were treated with either DMSO
or 5 M KU-60019 ATM kinase inhibitor prior to induction of lytic replication. The relative viral genome load was then
measured after 48 h by qPCR, while Western blots were used to monitor levels of total and phosphorylated CHK2. Expression
of viral K-bZIP was used to conﬁrm lytic replication of KSHV. (B and C) Control and AT ﬁbroblasts were de novo infected with
KSHV on glass coverslips and treated with sodium butyrate for 72 h. (B) IF analysis was then carried out for expression of SSB
and K8.1 lytic proteins. (C) The numbers of control and AT ﬁbroblasts containing viral RCs were then counted across a coverslip
in ﬁve repeat experiments. To assess release of infectious virus, supernatants from each cell line were then used to infect
EA.hy926 cells, and the number of infected cells was determined after 48 h by IF analysis of LANA expression. All data bars
represent the mean from ﬁve independent experiments, while error bars signify the SEM. *, P  0.05 (statistical analyses were
performed using a two-tailed and unpaired Student t test) (D) Vero and VK219-RTA cells were treated with doxycycline and
sodium butyrate for the indicated times, and Western blotting was used to assess the levels of total and phosphorylated ATM,
CHK2, and H2AX. VK219-RTA cells treated with either IR or UV were included as positive controls for DDR activation, while
blotting for the lytic proteins SSB and K8.1A conﬁrmed viral reactivation in VK219-RTA cells. (E) TREx BCBL-1-RTA cells were
treated with doxycycline, while Vero cells were de novo infected with KSHV and treated with sodium butyrate. After 48 h, IF
analysis was carried out for nuclear localization of Ku80 and MRE11 in relation to viral RCs marked by the viral SSB protein.
Scale bars represent 5 m.
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in this cell line, it also appears that recognition of viral genomes by DSB recognition
proteins is uncoupled from downstream DDR signaling.
Depletion of MRE11 and inhibition of its exonuclease activity have a negative
effect on viral replication. Since the MRN complex and Ku70/80 are the only factors
we have observed during this study that consistently colocalize with viral genomes, we
were interested to determine how inhibition of these DDR proteins would affect KSHV
replication. MRE11 has 3=-to-5= exonuclease activity that is required for DNA resection
prior to HR repair of DSBs (44). Due to the consistent localization of MRE11 to KSHV RCs,
the effect of mirin, a speciﬁc inhibitor of MRE11 exonuclease activity, on viral replication
was examined (Fig. 6A). Mirin was applied to TREx BCBL-1-RTA cells at a concentration
of 20 M at 1 h prior to induction of lytic replication using doxycycline. After 48 h, the
FIG 6 Effect of depletion of MRE11 and inhibition of its exonuclease activity on viral replication. (A and B)
TREx BCBL-1-RTA cells were treated with either DMSO or 20 M mirin prior to induction of lytic replication.
(A) The relative viral genome load was then measured after 48 h by qPCR, while supernatants were then
used to infect EA.hy926 cells, and the number of infected cells was determined after 48 h by IF analysis of
LANA expression. (B) Western blots were used to assess levels of total and phosphorylated CHK2 at 24 and
48 h after doxycycline treatment. Expression of viral K-bZIP was used to conﬁrm lytic replication of KSHV.
(C) VK219-RTA cells were treated with siRNA against MRE11 or control siRNA for 72 h, and Western blotting
was used to assess levels of MRN proteins. Following induction of lytic replication, the relative viral genome
load was measured after 72 h by qPCR, while supernatants were then used to infect HEK293 cells, and the
percentage of cells expressing GFP was determined after 48 h using ﬂow cytometry. (D) VK219-RTA cells
were treated with either DMSO or 20 M mirin prior to induction of lytic replication. The relative viral
genome load was measured after 72 h by qPCR, while supernatants were then used to infect HEK293 cells,
and the percentage of cells expressing GFP was determined after 48 h using ﬂow cytometry. All data bars
represent the mean from three independent experiments, while error bars signify the SEM. *, P  0.05; **,
P  0.01 (statistical analyses were performed using a two-tailed and unpaired Student t test).
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relative viral genome load was measured by qPCR, while production of infectious virus
was measured by applying infectious supernatants to EA.hy926 cells and calculating
the percentage of cells expressing the latent viral protein LANA using IF microscopy.
Application of mirin resulted in a consistent reduction in both viral genome ampliﬁ-
cation and production of infectious virus in TREx BCBL-1-RTA cells, indicating that the
exonuclease activity of MRE11 is required for efﬁcient viral replication.
Because the MRN complex facilitates recruitment and activation of ATM (14), we also
examined whether mirin inhibits activation of the ATM-CHK2 pathway that occurs
during KSHV replication in TREx BCBL-1-RTA cells. The effect of mirin on phosphoryla-
tion of CHK2 was therefore assessed in TREx BCBL-1-RTA cells at 24 and 48 h following
doxycycline treatment (Fig. 6B). In contrast to the effect the ATM kinase inhibitor, there
was no clear decrease in levels of phosphorylated CHK2 following mirin treatment at
either time point examined. This is consistent with the previous ﬁnding that MRE11
exonuclease activity is dispensable for ATM activation (54) and indicates that the
restrictive effect of mirin on viral replication in B cells is not due to impairment of
ATM-CHK2 signaling during the lytic cycle.
Since inhibition of MRE11 exonuclease activity abrogated KSHV replication, the
effect of small interfering RNA (siRNA) knockdown of MRE11 on viral replication was
also assessed (Fig. 6C). Since TREx BCBL-1-RTA cells are relatively resistant to transfec-
tion and recruitment of MRE11 to viral RCs is consistent across different cell types, these
experiments were performed in VK219-RTA cells. SmartPool siRNAs directed against
MRE11 and control nontargeting siRNAs were applied to VK219-RTA cells for 72 h, and
Western blotting was used to conﬁrm depletion of MRE11. Knockdown of MRE11 is
known to reduce stability of the other MRN components, NBS1 and RAD50 (55). As
expected, siRNA knockdown of MRE11 in VK219-RTA cells also led to a reduction in
levels of NBS1 and RAD50. Following MRE11 depletion, lytic replication was induced in
these cells, and the relative viral genome load was then measured by qPCR after 72 h.
Because this cell line contains a recombinant KSHV that expresses GFP during latency,
production of infectious virus from these cells was measured by infecting HEK293 cells
with infectious supernatants and determining the percentage expressing GFP 48 h later
using ﬂow cytometry. Depletion of MRE11 resulted in a signiﬁcant reduction in both
viral genome ampliﬁcation and release of infectious virus in VK219-RTA cells, although
this decrease was less pronounced than the effect of mirin in TREx BCBL-1-RTA cells.
The effect of mirin on viral replication in VK219-RTA cells was also examined
(Fig. 6D). Mirin was applied 1 h prior to viral reactivation, and viral genome ampliﬁca-
tion and infectious virus release were measured by qPCR and ﬂow cytometry, respec-
tively. Similar to the case in TREx BCBL-1-RTA cells, mirin had a negative effect on viral
genome ampliﬁcation and release of infectious virus in VK219-RTA cells, although only
the decrease in relative viral genome load reached statistical signiﬁcance. Overall, these
results indicate that the MRE11 protein contributes to efﬁcient lytic replication of KSHV.
Knockdown of Ku80 and inhibition of DNA-PK enhances viral replication. Our
previous ﬁndings demonstrated that inhibition of DNA-PK in TREx BCBL-1-RTA cells
using the speciﬁc inhibitor NU7441 resulted in increased release of infectious virus and
enhanced phosphorylation of ATM substrates during lytic replication of KSHV (33). To
conﬁrm that DNA-PK inhibition can enhance ampliﬁcation of KSHV DNA in these cells,
the effect of NU7441 on the relative viral genome load was assessed by qPCR (Fig. 7A).
Addition of NU7441 to TREx BCBL-1-RTA cells prior to doxycycline treatment resulted in
a dramatic reduction in the phosphorylation of RPA32 at serines 4 and 8 that occurs
during viral replication in these cells, conﬁrming that this phosphorylation event is
attributable to DNA-PK kinase activity. NU7441 also led to an increase in relative viral
genome load at 48 h following addition of doxycycline compared with the DMSO
control, indicating that DNA-PK activity has a negative effect on KSHV replication.
After binding to DNA ends, the Ku70/80 heterodimer recruits DNA-PKcs to form the
DNA-PK enzyme, which participates in NHEJ. Due to its consistent localization to KSHV
RCs and its association with DNA-PKcs, the effect of Ku80 knockdown on KSHV lytic
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replication was also assessed (Fig. 7B). As with depletion of MRE11, Ku80 knockdown
was carried out in VK219-RTA cells at 72 h prior to induction of lytic replication, and
Western blotting was used to monitor levels of Ku80 and its binding partner, Ku70.
Since the interaction between Ku70 and Ku80 promotes stability of both proteins (56),
depletion of Ku80 also led to a reduction in levels of Ku70 in VK219-RTA cells. As before,
lytic replication was then induced in these cells, and the relative genome load and
release of infectious virus were assessed by qPCR and ﬂow cytometry, respectively, after
72 h. In contrast to the negative effect of MRE11 knockdown, reduction of Ku80 led to
a dramatic increase in the viral genome load after 72 h. Ku80 depletion also led to
increased release of infectious virus from these cells, although the relative increase
observed was less than the increase in viral genome load.
FIG 7 Effect of depletion of Ku80 and inhibition of DNA-PK activity on viral replication. (A) TREx
BCBL-1-RTA cells were treated with either DMSO or 1 M NU7441 DNA-PK inhibitor prior to induction of
lytic replication. The relative viral genome load was then measured after 48 h by qPCR, while Western
blots were used to monitor levels of total and phosphorylated RPA32. Expression of viral K-bZIP was used
to conﬁrm lytic replication of KSHV. (B) VK219-RTA cells were treated with siRNA against Ku80 or control
siRNA, and Western blotting was used to monitor levels of Ku80 and Ku70 after 72 h. Following induction
of lytic replication, the relative viral genome load was measured after 72 h by qPCR, while supernatants
were then used to infect HEK293 cells, and the percentage of cells expressing GFP was determined after
48 h using ﬂow cytometry. (C) VK219-RTA cells were treated with either DMSO or 1 M NU7441 DNA-PK
inhibitor prior to induction of lytic replication. After 72 h, qPCR was used to assess the relative genome
load, while supernatants were then used to infect HEK293 cells, and the percentage of cells expressing
GFP was determined after 48 h using ﬂow cytometry. All data bars represent the mean from three
independent experiments, while error bars signify the SEM. *, P  0.05; **, P  0.01 (statistical analyses
were performed using a two-tailed and unpaired Student t test).
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The effect of DNA-PK kinase inhibition on viral replication in VK219-RTA cells was
also evaluated by application of NU7441 prior to induction of viral replication (Fig. 7C).
As with TREx BCBL-1-RTA cells, application of this compound to VK219-RTA cells
resulted in a signiﬁcant increase in viral genome load and release of infectious virus at
72 h after lytic reactivation. Overall, these ﬁndings indicate that, in contrast to the case
for ATM and MRE11, components of the NHEJ pathway exert a restrictive effect on KSHV
replication.
DISCUSSION
Here we have presented a comprehensive assessment of the localization of DSB
repair factors during lytic replication of KSHV. We have conﬁrmed that the complete
MRN complex and the Ku70/80 heterodimer, which recognize and bind DSBs, consis-
tently colocalize with viral genomes as RCs expand to ﬁll the nuclear space. Interest-
ingly, BRCA1 and CtIP, which can form a complex with MRN during DNA repair, were
also observed at KSHV RCs but not as consistently as the MRN complex. The interaction
between these proteins and MRN relies on the phosphorylation of CtIP by CDKs, which
restricts formation of the complex, and therefore DNA resection, to the S and G2 phases
of the cell cycle (57). Previous research has indicated that lytic replication of KSHV
occurs in G1, which would explain the lack of localization of these factors to RCs (58).
However, our earlier ﬁndings indicate that in B cells, induction of lytic replication leads
to an increase in the number of cells in S phase (33). It is possible, therefore, that KSHV
lytic replication can occur in both G1 and S phases and that localization of BRCA1 and
CtIP to viral RCs is cell cycle dependent. Whether recruitment of CtIP and BRCA1 to RCs
has a positive or negative effect on viral genome replication was not evaluated here but
would be an interesting avenue of investigation for future research.
With the exception of RAD52, other factors examined that participate in HR repair
downstream of DNA end resection did not localize to viral RCs. In the case of RAD51,
the lack of recruitment to viral genomes was unexpected considering that this protein
has been observed at sites of both HSV-1 and EBV DNA synthesis and has also been
implicated in efﬁcient replication of both of these herpesviruses (38, 39, 59). In the case
of HSV-1, knockdown of the HR factors RAD51 and RAD52 abrogates recombination
events between viral genomes, while a separate study demonstrated that individual
depletion of RAD51, RAD52, and RAD54 dramatically reduced HSV-1 replication levels
following exposure of the viral genomes to UV radiation (46, 59). While these studies
have implicated cellular HR factors in viral replication, it has also been shown that the
HSV-1 ssDNA binding protein ICP8 and the viral alkaline nuclease UL12 can form a
two-component recombinase that catalyzes in vitro strand exchange reactions similarly
to the phage lambda Red / (60). UL12 and ICP8 also interact with members of the
MRN complex, raising the possibility that viral and cellular proteins can cooperate
to promote recombination events that enhance the ﬁdelity of herpesvirus replica-
tion (61, 62).
The formation of H2AX, MDC1, and 53BP1 foci outside viral RCs suggests that
cellular DNA damage can occur during the KSHV lytic replication phase. The occurrence
of DNA damage during KSHV replication has previously been demonstrated using
comet assays, while the lytic ORF57/MTA protein has also been shown to cause DNA
damage when ectopically expressed in HEK293 cells (41, 63). Confocal images from the
present study conﬁrm that DSB repair factors aggregate on the margins of viral RCs,
although it is not currently clear why DNA damage would be concentrated in these
areas. One explanation is that the rapid expansion of these viral replication structures
causes physical compaction of cellular chromatin resulting in DNA fragmentation.
Despite this, it is unlikely that expansion of RCs would be the sole cause of cellular DNA
damage in this setting. This is because we have previously demonstrated that inhibition
of viral DNA ampliﬁcation, and therefore expansion of viral RCs, in B cells does not
reduce phosphorylation of DDR proteins following lytic reactivation (33). Based on this
observation, as well as the previous identiﬁcation of herpesvirus proteins that can cause
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DNA damage when expressed alone, it is possible that numerous events unique to the
lytic replication phase can contribute to the formation of cellular DNA lesions.
We have also presented evidence here that newly ampliﬁed KSHV DNA is not
associated with cellular histones. Histone deposition on replicating KSHV genomes has
not previously been examined, although the fact that KSHV DNA has been shown to be
histone free in the virion particle provides additional evidence of histone exclusion
during the lytic cycle (64, 65). Posttranslational modiﬁcations of histones that ﬂank sites
of DSBs play critical roles in regulating assembly of repair complexes and in orches-
trating cell cycle checkpoint activation (66). The lack of histones on viral DNA would
explain why proteins such as MDC1 and 53BP1 are not concentrated at viral RCs despite
the apparent occurrence of DSBs in viral DNA that are recognized by the DDR, since
these proteins are recruited to DSBs following recognition of histones modiﬁcations at
break sites (18, 19). Although localization of ATM was not examined here, it is possible
that this kinase is recruited to viral DSBs even though viral replication does not result
in stimulation of ATM-CHK2 signaling. This is because, while MRN can recruit ATM to
DSBs together with the TIP60 acetyltransferase, efﬁcient activation of ATM kinase
activity requires an interaction between TIP60 and histone H3 trimethylated on lysine
9 (H3K9me3) (67). Formation of phosphorylated ATM foci has also been shown to be
dependent on the interaction between H2AX and MDC1 that occurs following DSBs
(18). Ultimately, the absence of histone deposition by KSHV may be part of a strategy
to avoid localization of DNA repair factors that would otherwise lead to detrimental
processing of viral DNA.
Ambiguity regarding the requirement of the ATM kinase for lytic replication of
herpesviruses is a recurring theme in studies regarding these pathogens and the DDR.
We have shown here, and in more depth previously, that lytic reactivation in B cells
leads to robust activation of the ATM-CHK2 pathway and that inhibition of this
response has a negative effect on viral replication in this cell line. Results derived using
AT ﬁbroblasts, which lack functional ATM, demonstrate that although ATM may en-
hance KSHV replication, it is not absolutely required for completion of the lytic cycle.
The further ﬁnding that ATM-CHK2 activation is a cell line-speciﬁc event also highlights
the redundancy of this signaling pathway for ampliﬁcation of viral DNA and release of
infectious progeny. It is currently unclear why ATM is activated during KSHV replication
in B cells but not in Vero cells despite robust phosphorylation of H2AX in both cell lines
indicating DNA damage. However, the consistent recruitment of DSB-sensing proteins
to viral RCs in Vero cells in the absence of ATM-CHK2 signaling does demonstrate that
recognition of viral DSBs by the cellular DDR is uncoupled from activation of this
downstream signaling pathway.
We have also assessed the contribution of DSB repair factors to efﬁcient replication
of KSHV. This assessment was restricted to those proteins that consistently localized to
viral RCs as well as proteins for which a speciﬁc inhibitor was commercially available.
While application of the MRE11 exonuclease inhibitor reduced levels of viral replication
in B cells by approximately 50%, knockdown of MRE11 in VK219 cells had a more
moderate negative effect despite efﬁcient depletion of this protein prior to viral
reactivation. It is possible that only small amounts of MRE11 are necessary for viral
replication, although since MRE11-null cells are not viable, it is difﬁcult to ascertain how
complete loss of this protein would impact synthesis of viral DNA. Although localization
of MRN to viral RCs has been observed in several species of herpesvirus (35, 38), a
speciﬁc role for this complex during lytic replication of these pathogens has yet to be
identiﬁed. Interestingly, MRN proteins have antiviral functions at an earlier stage in the
herpesvirus life cycle, as it has been demonstrated that a RAD50-MRE11-CARD9 com-
plex can recognize KSHV DNA in the cytoplasm and trigger activation of the NF-B
pathway to suppress viral replication (68, 69). MRN can also abrogate replication of
adenovirus DNA, and it has recently been shown that an interaction between MRN and
adenovirus genomes promotes a limited ATM response that speciﬁcally restricts viral
but not cellular DNA replication (70). Serotype-speciﬁc degradation, redistribution, and
inactivation of MRN components during adenovirus infection have also previously been
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documented (71–73). While MRN has a well-deﬁned role in DSB detection and repair,
the complex has also been shown to associate with replicating DNA during S phase and
to promote replisome stability and replication restart following fork stalling (74, 75). It
is conceivable that MRN contributes similarly to replication of herpesvirus DNA, al-
though why this cellular complex is apparently beneﬁcial to some double-stranded
DNA viruses while detrimental to others remains enigmatic.
Depletion of the NHEJ factor Ku80 resulted in an increase in viral DNA ampliﬁcation
and release of infectious virus in VK219-RTA cells, while inhibition of DNA-PK enzymatic
activity also enhanced viral replication in both VK219-RTA and TREx BCBL-1-RTA cells.
DNA afﬁnity puriﬁcation and mass spectrometry have previously been used to show
that both the Ku70/80 heterodimer and DNA-PKcs bind to the KSHV origin of lytic
replication in induced BCBL-1 cells, indicating that the complete DNA-PK holoenzyme
can interact with KSHV genomes following lytic reactivation (76). Further evidence for
a restrictive role for DNA-PK in KSHV replication comes from a previous study showing
that the viral PF8 protein blocks the interaction between Ku70/80 and DNA-PKcs,
resulting in inhibition of NHEJ (63). The ﬁndings presented here are also in agreement
with research in HSV-1 demonstrating that viral replication is enhanced in Ku-deﬁcient
murine embryonic ﬁbroblasts and in DNA-PKcs-deﬁcient glioma cells (62, 77). None of
these previous investigations have clariﬁed exactly how the NHEJ pathway attenuates
replication of herpesvirus DNA, although it has been suggested that activation of this
pathway could lead to inappropriate ligation of viral replication products during
cleavage of concatemeric DNA (77, 78).
In summary, the results presented in this study indicate that DSBs form in viral DNA
during lytic replication of KSHV and elicit a host DDR that is distinct from the response
to cellular DSBs (Fig. 8). Cellular DSBs typically result in activation of ATM and DNA-PK,
leading to phosphorylation of multiple substrates that orchestrate assembly of DNA
repair foci and cell cycle checkpoint activation. In contrast, viral DNA breaks result in a
more limited DDR that involves localization of sensor proteins, potentially DNA-PK and
ATM, but not downstream phosphorylation of transducer and effector proteins.
It is now established that DSB repair proteins localize to KSHV genomes in the
cytoplasm and cooperate in cellular antiviral immune responses (31, 68). The ﬁndings
presented here indicate that the DDR also exerts an antiviral effect during lytic
replication through components of the NHEJ repair pathway. While we have not
demonstrated conclusively that speciﬁc DDR factors are essential for KSHV lytic repli-
cation, it appears that ATM and MRE11 promote efﬁcient synthesis of viral genomes
and release of infectious progeny. Overall, this study highlights the complex relation-
ship between KSHV and the cellular DSB repair machinery and further demonstrates
how lytic replication of herpesviruses inevitably involves selective interactions with
host DDR signaling pathways.
FIG 8 Model of the DDR to cellular and viral DSBs. Cellular DSBs elicit ATM and DNA-PK activation leading
to widespread DDR signaling. In contrast, DSBs in viral DNA result in a more limited DDR involving
recruitment of DSB-sensing complexes but not downstream phosphorylation of transducer and effector
proteins.
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MATERIALS AND METHODS
Cell culture and drug additions. All cell lines used in this study were cultured in a humidiﬁed
incubator at 37°C with 5% CO2. TREx BCBL-1-RTA cells (developed by Jae Jung, University of Southern
California, USA) (79) were maintained in RPMI growth medium (Sigma-Aldrich) supplemented with 10%
fetal bovine serum (FBS) (Sigma-Aldrich), 1% penicillin-streptomycin (Gibco), and 100 g/ml of hygro-
mycin B (Roche). EA.hy926 cells (purchased from ATCC), HEK293 cells (purchased from ATCC), and
ataxia-telangiectasia (AT) and control dermal ﬁbroblasts (provided by Malcolm Taylor, University of
Birmingham, UK) were cultured in Dulbecco modiﬁed Eagle medium (DMEM) (Sigma-Aldrich) supple-
mented with 10% FBS and 1% penicillin-streptomycin. EA.hy926-RTA cells, which express ORF50/RTA
under the control of the tetracycline promoter, were also cultured in the presence of 250 g/ml of G418
(Sigma-Aldrich). VK219-RTA cells (provided by Andrew Hislop, University of Birmingham, UK), which
contain the recombinant rKSHV.219 virus and express ORF50/RTA under the control of the tetracycline
promoter, were maintained in AQ medium (Sigma-Aldrich) supplemented with 10% FBS, 1% penicillin-
streptomycin, 5 g/ml puromycin (Sigma-Aldrich), and 250 g/ml G418. Vero cells were cultured in the
same medium but in the absence of G418 and puromycin. U2OS cells expressing doxycycline-inducible
GFP-tagged CtIP (developed by Alessandro Sartori, University of Zurich, Switzerland) (45) were cultured
in DMEM supplemented with 10% FBS, 1% penicillin-streptomycin, 100 g/ml hygromycin B, and 5
g/ml blasticidin (Sigma-Aldrich). Latent KSHV within TREx BCBL-1-RTA and EA.hy926-RTA cells was
reactivated by the addition of 0.5 g/ml doxycycline, while VK219-RTA cells were induced by the addition
of 1 g/ml doxycycline and 0.5 mM sodium butyrate.
Stock solutions of the MRE11 exonuclease inhibitor mirin, the ATM kinase inhibitor KU-60019, and the
DNA-PK inhibitor NU7441 (all purchased from Tocris Bioscience) were prepared in DMSO. These com-
pounds, and appropriate DMSO vehicle controls, were added to cells 1 h prior to stimulation of lytic
replication. Supernatants were collected at the indicated time points and assessed for infectious virus
levels, while cells were also harvested and evaluated for relative viral genome load using qPCR as
outlined below.
De novo infection of cells with KSHV. In order to quantify infectious virus production from induced
VK219-RTA cells, supernatants containing infectious KSHV were added directly to HEK293 cells in culture
plates that were then spinoculated (330  g, 20 min, room temperature) and cultured for 4 h at 37°C.
Virus-containing supernatants were then removed and replaced with normal supplemented medium.
After 48 h, cells were harvested and ﬁxed in 4% paraformaldehyde, and a minimum of 10,000 cells were
assessed to determine the percent GFP expression relative to that in uninfected controls using an Accuri
C6 ﬂow cytometer (BD). Quantiﬁcation of infectious virus production from induced TREx BCBL-1-RTA cells
was carried out as described above except that supernatants were added to EA.hy926 cells which were
subsequently analyzed for expression of the viral protein LANA using the IF microscopy protocol outlined
below. In this case, a minimum of 500 cells were analyzed in each of three independent experiments.
To assess KSHV replication in ﬁbroblasts, TREx BCBL-1-RTA cells were resuspended in antibiotic-free
medium containing 0.5 g/ml doxycycline at a density of 5  105 cells/ml. After 72 h, cells were pelleted
and supernatant containing infectious KSHV was applied directly to AT and control ﬁbroblasts grown on
13 mm coverslips in 24-well plates. Cells were spinoculated (330  g, 20 min, room temperature) and
cultured for 6 h at 37°C. After 24 h, infectious supernatants were removed, cells were washed twice with
phosphate-buffered saline (PBS), and fresh culture medium containing 0.5 mM sodium butyrate (Sigma-
Aldrich) was added. After a further 72 h, cells were ﬁxed for assessment of viral gene expression using
IF microscopy. To assess production of infectious virus from these cells, supernatants were added directly
to EA.hy926 cells in culture plates which were spinoculated as outlined above. After 48 h, EA.hy926 cells
were then analyzed for LANA expression using the IF microscopy protocol outlined below.
In order to visualize KSHV RCs, EA.hy926-RTA cells were grown on glass coverslips and infected with
TREx BCBL-1-RTA-derived KSHV as outlined above except that cells were cultured with the virus for 4 h
at 37°C before infectious supernatants were removed and replaced with fresh culture medium. After an
additional 24 h, cells were treated with 0.5 g/ml doxycycline for 48 h to induce lytic replication before
being ﬁxed and stained as outlined below.
IF microscopy. Adherent cells were grown on glass coverslips in 24-well plates, while suspension
cells were cytospun onto glass slides. Cells were either ﬁxed in 4% paraformaldehyde in PBS for 10 min
and permeabilized in 0.5% Triton X-100 for 5 min in PBS or preextracted on ice for 5 min with nuclear
extraction buffer [10 mM piperazine-N,N=-bis(2-ethanesulfonic acid) (PIPES), 20 mM NaCl, 3 mM MgCl2,
300 mM sucrose, 0.5% Triton X-100] before being ﬁxed in 4% paraformaldehyde in PBS for 10 min. Cells
were blocked in 10% heat-inactivated goat serum (HINGS) for 30 min before addition of primary
antibodies diluted in 10% HINGS for 1 h at room temperature. Cells were washed three times in PBS
before addition of Alexa Fluor-conjugated secondary antibodies diluted in 10% HINGS for 1 h at room
temperature. Cells were washed three times in PBS before addition of DAPI (4=,6=-diamidino-2-
phenylindole) nuclear stain diluted in PBS for 1 min (Life Technologies). Coverslips were mounted using
Prolong Gold antifade reagent (Life Technologies). Fluorescence images were taken using a Leica
DM6000B epiﬂuorescence microscope with Leica Application Suite Advanced Fluorescence software. For
confocal immunoﬂuorescence microscopy (IF), EA.hy926-RTA cells were prepared as described above.
z-stack images made up of 1-m optical sections were then generated using a Nikon A1R confocal laser
microscope system with Nikon NIS-Elements software and processed using ImageJ software.
The following primary antibodies were used for IF microscopy: anti-LANA (NCL-HHV8-LNA; Novacas-
tra), anti-ORF6/SSB (provided by Gary Hayward, Johns Hopkins University, MD, USA), anti-ORF59/PF8
(in-house), anti-K8.1 (in-house), anti-MRE11 (GTX70212; Genetex), anti-NBS1 (GTX70222; Genetex), anti-
RAD50 (ab89; Abcam), anti-Ku80 (GTX70276; Genetex), anti-Ku70 (ab83501; Abcam), anti-BRCA1 (sc-6954;
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Santa Cruz), anti-RAD51 (PC130; Merck Millipore), anti-RAD52 (sc-8350; Santa Cruz), anti-RAD54B
(GTX103291; Genetex), anti-H2AX (S139) (05-636; Merck Millipore), anti-MDC1 (in-house), anti-53BP1
(ab36823; Abcam), anti-histone H1 (39708; Active Motif), and anti-histone H3 (GTX122148; Genetex).
siRNA transfections. siRNA On-Target Plus Smart pools targeting XRCC5 (Ku80) (L-010491-00-0005)
and MRE11A (L-009271-00-0005), as well as a nontargeting control pool (D-001810-10-05) (Dharmacon),
were resuspended to 20 M stock solutions in siRNA buffer (Dharmacon). VK219-RTA cells were
transfected with siRNAs at a concentration of 10 nM in 6-cm dishes using Lipofectamine RNAiMAX
(Invitrogen) according to the manufacturer’s instructions. siRNAs and RNAiMAX were diluted in Opti-
MEM (Gibco) and applied directly to cell culture medium following 20 min of incubation at room
temperature. After 72 h, the medium was replaced, lytic reactivation was induced by the addition of
1 g/ml doxycycline and 0.5 M sodium butyrate, and cells were left for an additional 72 h. Supernatants
were then collected for analysis of infectious virus production using ﬂow cytometry, while cells were
harvested for analysis of relative viral genome load by qPCR.
Western blot analysis. Cell lysates were prepared by sonicating in UTB buffer (8 M urea, 50 mM Tris
HCl [pH 7.4], 150 mM -mercaptoethanol). Following protein concentration determination using the
Bradford reagent (Bio-Rad), lysates were suspended in 2 Laemmli sample buffer (Bio-Rad) and heated
to 95°C for 10 min. Lysates were then subjected to sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) using standard procedures.
The following primary antibodies were used for Western blotting: anti-K8/K-bZIP (SAB5300152;
Sigma-Aldrich), anti-ORF6/SSB (provided by Gary Hayward), anti-K8.1A (in-house), anti--actin (A2228;
Sigma-Aldrich), anti-ATM (2873; Cell Signaling), anti-phospho-ATM (S1981) (AF1655; R&D Systems),
anti-CHK2 (2662; Cell Signaling), anti-phospho-CHK2 (T68) (2661; Cell Signaling), anti-RPA32 (NA19L;
Calbiochem), anti-phospho-RPA32 (S4/S8) (A300-245A; Bethyl), anti-H2AX (7631; Cell Signaling), anti-
H2AX (S139) (05-636; Merck Millipore), anti-MRE11 (GTX70212; Genetex), anti-NBS1 (GTX70222; Gene-
tex), anti-RAD50 and anti-KU80 (sc-6954; Santa Cruz), and anti-KU70 (ab83501; Abcam). Goat anti-mouse
and swine anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibodies (Dako Laborato-
ries) and ECL detection reagent (GE Healthcare) were used to visualize proteins on a Fusion SL
chemiluminescence imaging system (Vilber Lourmat).
qPCR. To assess the relative viral genome load in KSHV-infected cells, DNA was extracted using a
Wizard genomic DNA puriﬁcation kit (Promega) according to the manufacturer’s instructions and
quantiﬁed by UV spectrophotometry. Ampliﬁcation reactions were performed in 20-l volumes contain-
ing 10 l SensiFAST SYBR master mix (Bioline), 0.1 M forward and reverse primers, and 50 ng DNA
template. Cycling was performed on an Applied Biosystems 7500 Fast Dx real-time PCR machine using
an initial denaturation at 94°C for 3 min followed by 40 cycles of a 5-s denaturation at 94°C, a 10-s
annealing at 60°C, and a 20-s extension at 72°C. Samples were run in triplicate, and dissociation curve
analysis was used to conﬁrm that each primer pair generated a single product. The viral genome load
was then calculated relative to that in uninduced cells containing latent KSHV. Viral DNA was detected
using primers speciﬁc to the KSHV ORF47 gene (sequences provided by Adrian Whitehouse, University
of Leeds, UK) and normalized to cellular DNA using previously published primers to the cellular
2-microglobulin (B2m) gene (80). Fold changes relative to uninduced controls were then calculated
using the comparative threshold cycle (CT) method. For ChIP experiments, viral DNA was also detected
using previously published primers against the KSHV left origin of lytic replication (OriLytL) (5). Primers
used in quantitative PCRs (qPCRs) were B2m-Fwd (5=-GGAATTGATTTGGGAGAGCATC3=) and B2m-Rev
(5=-CAGGTCCTGGCTCTACAATTTACTAA-3=), ORF47-Fwd (5=-CGCGGTCGTTCGAAGATTGGG-3=) and ORF47-
Rev (5=-CGAGTCTGACTTCCGCTAACA-3=), and OriLytL-Fwd (5=-GGGGGGGGGCTAGTGAGTCA-3=) and
OriLytL-Rev (5=-GTAACAGTTGGTTAACCCGT-3=).
ChIP. TREx BCBL-1-RTA cells were treated with 0.5 g/ml doxycycline for 0, 24, and 48 h. Chromatin
immunoprecipitation (ChIP) was then carried out using an Active Motif Chip-It express kit according to
the manufacturer’s instructions. In brief, 1.5  107 cells per condition were cross-linked for 10 min in 1%
formaldehyde before neutralization with 0.125 M glycine. Following lysis, cells were subjected to
sonication for 8 min (30 s on and 30 s off). A proportion of the chromatin from each condition was
cleaned up using phenol-chloroform extraction to provide input DNA samples that were subsequently
subjected to qPCR analysis of relative viral genome load as outlined above. Chromatin-protein complexes
were immunoprecipitated from the remaining chromatin using protein G-coated magnetic beads (Active
Motif) and antibodies against histone H3 (D2B12; Cell Signaling) or normal rabbit IgG (2729; Cell
Signaling). Following washing and elution of the protein-DNA complexes, cross-links were reversed by
heating and treatment with proteinase K (Active Motif).
The relative quantities of viral and cellular DNA fragments present following immunoprecipitations
were determined using qPCRs as outlined above. Background values obtained from immunoprecipita-
tion reactions using the control IgG antibody were subtracted from the values obtained using the
antibody against histone H3. Values for viral DNA at each time point were also normalized to values
derived from cellular DNA to account for differences in immunoprecipitation efﬁciencies.
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